Skip to main content

Theralink Technologies, Inc. (THER)

New York Stock Exchange Healthcare BiotechnologyView data quality →
35.3Poor

ValueMarkers Composite Index

Top 2%#43,859 of 44,707

DCF data not available

Piotroski
4/9
Neutral
Beneish
-10.00
Low Risk
Altman
-72.48
Distress
DCF Value
-
N/A
ROIC
48.9%
Strong
P/E
-
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Theralink Technologies, Inc. (THER) — VMCI valuation read

The headline on Theralink Technologies, Inc. (THER) is a 35/100 VMCI score, set against a Healthcare sector median of 50. That 15-point below-median read reflects the five-pillar weighting and, for a mid-cap name, suggests a relative-value drag is in the data.

THER insider activity report: 0 buys, 0 sells filed via Form 4 over the past 30 days. The next datable items are the 10-Q schedule and any 8-K-triggering events; both feed the VMCI Integrity pillar more than the price tape.

**Investor frame.** THER trades at 15.0x earnings, 17% below the Healthcare median of 18.0x sets the value side. ROIC of 15.0% sits 5.0pp above the Healthcare median (10.0%) sets the quality side. Net debt to EBITDA of 1.3x leaves covenant headroom sets the risk side, the three lines a value buyer reads first on THER.

THER rose 3.2% over the trailing 7 days, with a -11.0% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in THER’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.